Ignite Creation Date:
2024-05-06 @ 6:38 PM
Last Modification Date:
2024-10-26 @ 2:52 PM
Study NCT ID:
NCT05738317
Status:
RECRUITING
Last Update Posted:
2023-02-22
First Post:
2023-02-12
Brief Title:
Adebrelimab Combined With Bevacizumab and Albumin Paclitaxel in Non-squamous NSCLC After First-line Treatment
Sponsor:
Xiaorong Dong
Organization:
Wuhan Union Hospital China
Organization Data
Organization:
Wuhan Union Hospital China
Class:
OTHER
Study ID:
MA-NSCLC-II-026
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Xiaorong Dong
Lead Sponsor Class:
OTHER
Responsible Party:
Xiaorong Dong
Responsible Party Title:
ProfessorChief Physician
Responsible Party Type:
SPONSOR_INVESTIGATOR
Responsible Party Affiliation:
Wuhan Union Hospital China
Old Name:
None
Old Organization:
None